The invention relates to a MnO2 in-situ coated nano
diamond drug, which is prepared by the following steps: by taking nano
diamond as a carrier, modifying the surface of the nano
diamond with
polylysine so as to improve the
dispersity and provide amino groups, then connecting the nano diamond with
glucose oxidase rich in carboxyl groups through an
amide reaction, and then
coating the surface of the nano diamond with MnO2 through KMnO4 reduction so as to obtain the MnO2 in-situ coated nano diamond
drug. Finally, the chemotherapeutic
drug DOX is loaded through coordination and
electrostatic interaction. According to the nano diamond
medicine, in a subacid
tumor microenvironment rich in GSH, the wrapped MnO2 shell is subjected to a
redox reaction to generate Mn < 2 + >, meanwhile, the MnO2 nano structure can trigger H2O2 in the
tumor microenvironment to be decomposed to generate O2,
tumor hypoxia can be relieved, GOx can be exposed, glucose in a tumor area can be effectively catalyzed to generate H2O2 under the aerobic condition, and therefore the
tumor hypoxia can be relieved. Glucose consumption effectively cuts off
nutrition sources of
tumor cells, inhibits tumor
cell proliferation and realizes tumor hunger treatment. According to the invention,
chemotherapy, hunger therapy and
chemical kinetics therapy are cooperated to efficiently and selectively kill
tumor cells, and a remarkable anti-tumor effect is achieved.